Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong
· Delayed Price · Currency is HKD 0.189
0.00 (0.00%)
Apr 28, 2026, 2:20 PM HKT
HKG:6833 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 34.85 | 42.05 | 42.35 | 69.46 | 135.08 | Upgrade
|
| Depreciation & Amortization | 25.5 | 24.42 | 16.32 | 11.36 | 6.68 | Upgrade
|
| Other Amortization | 0.08 | 0.08 | 0 | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 1.14 | -0.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -0.28 | -0.16 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.1 | -3.92 | 4.25 | 6.21 | 1.02 | Upgrade
|
| Other Operating Activities | 39.4 | 28.64 | 45.97 | -5.97 | 22.5 | Upgrade
|
| Change in Accounts Receivable | 4.08 | -71.98 | -195.89 | -133.87 | 364.07 | Upgrade
|
| Change in Inventory | 92.78 | -244.31 | -19.88 | -26.88 | 181.29 | Upgrade
|
| Change in Accounts Payable | 21.36 | 55.39 | 444.18 | -21.2 | -277.39 | Upgrade
|
| Change in Unearned Revenue | -8.88 | -12.73 | -34.97 | 47.68 | -0.06 | Upgrade
|
| Change in Other Net Operating Assets | -8.69 | -51.65 | 51.41 | 128.57 | -127.34 | Upgrade
|
| Operating Cash Flow | 207.59 | -232.88 | 353.7 | 75.08 | 305.71 | Upgrade
|
| Operating Cash Flow Growth | - | - | 371.09% | -75.44% | 122.66% | Upgrade
|
| Capital Expenditures | -10.03 | -35.16 | -29.55 | -52.69 | -23.52 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | 0.91 | 0.3 | - | Upgrade
|
| Cash Acquisitions | - | - | - | -68 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -17.78 | -17.92 | -15.11 | - | - | Upgrade
|
| Other Investing Activities | - | 0.21 | -19.87 | 1.12 | 0.8 | Upgrade
|
| Investing Cash Flow | -27.81 | -52.87 | -63.63 | -119.27 | -22.73 | Upgrade
|
| Long-Term Debt Issued | 298.92 | 361.1 | 180.02 | 180 | 210 | Upgrade
|
| Total Debt Issued | 298.92 | 361.1 | 180.02 | 180 | 210 | Upgrade
|
| Long-Term Debt Repaid | -466.05 | -306.34 | -123.97 | -341.45 | -78.66 | Upgrade
|
| Total Debt Repaid | -466.05 | -306.34 | -123.97 | -341.45 | -78.66 | Upgrade
|
| Net Debt Issued (Repaid) | -167.13 | 54.76 | 56.05 | -161.45 | 131.34 | Upgrade
|
| Issuance of Common Stock | - | - | - | 159.46 | 75.37 | Upgrade
|
| Common Dividends Paid | -3.67 | -7.22 | -18.11 | - | - | Upgrade
|
| Other Financing Activities | -65.28 | 107.05 | -227.66 | 37.03 | -303.83 | Upgrade
|
| Financing Cash Flow | -236.08 | 154.59 | -189.73 | 35.04 | -97.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.82 | 1.56 | 8.43 | 12.24 | -3.59 | Upgrade
|
| Net Cash Flow | -59.12 | -129.6 | 108.78 | 3.09 | 182.29 | Upgrade
|
| Free Cash Flow | 197.55 | -268.04 | 324.15 | 22.39 | 282.19 | Upgrade
|
| Free Cash Flow Growth | - | - | 1347.74% | -92.07% | 106.09% | Upgrade
|
| Free Cash Flow Margin | 9.48% | -9.50% | 12.76% | 0.99% | 13.94% | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -0.13 | 0.16 | 0.01 | 0.16 | Upgrade
|
| Cash Interest Paid | 33.94 | 16.64 | 14.43 | 18.33 | 22.47 | Upgrade
|
| Cash Income Tax Paid | 19.09 | 62.2 | 37.37 | 39.66 | 41.69 | Upgrade
|
| Levered Free Cash Flow | 116.17 | -175.42 | 111.78 | 57.81 | -85.98 | Upgrade
|
| Unlevered Free Cash Flow | 125.77 | -167.57 | 117.91 | 66.44 | -72.58 | Upgrade
|
| Change in Working Capital | 100.65 | -325.27 | 244.85 | -5.7 | 140.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.